Many people are being prescribed pregabalin for short durations and in low doses inconsistent with its recommended indication of chronic neuropathic pain, an Australian study shows. The pattern of pregabalin use revealed by PBS data suggests it is being used inappropriately for short term treatment of low back pain and in combination with opioids, according ...
Pregabalin often used ‘off label’ for non-neuropathic pain, PBS figures show
By Michael Woodhead
18 Mar 2020